Bezuclastinib's upcoming data in July 2025 could be a game-changer for COGT, offering a lucrative investment opportunity. See ...
Officer of Adaptimmune Therapeutics PLC (NASDAQ:ADAP), executed a sale of 5,584 American Depositary Shares (ADS) on January ...
In a recent transaction, William C. Bertrand Jr., the Chief Operating Officer of Adaptimmune Therapeutics PLC (NASDAQ:ADAP), ...
Elizabeth L. Hougen, Executive Vice President, Finance & CFO of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), recently executed several transactions involving the company's common stock. According to a ...
Biosciences Inc. (NASDAQ:NBIX), a biopharmaceutical company with robust financials and an "GREAT" health score according to ...
Pharmaceuticals announced that the U.S. FDA has accepted the New Drug Application for investigational plozasiran for the ...
Hosted on MSN15h
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 SalesKey Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...
Investor's Business Daily on MSN17h
Here's How Donald Trump Could Shake Up Health Care — And Biotech StocksBiotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
Hosted on MSN18h
How to Play Moderna Stock After the Recent Sales Guidance CutModerna MRNA provided an update on its financial outlook and pipeline progress at the J.P. Morgan Healthcare Conference. At ...
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback